Torrent Pharmaceuticals today said its consolidated net profit rose by 8.15% to Rs 83.18 crore for the quarter ended December 31, 2011, vis-a-vis the same period last fiscal, mainly on the back of growth in international revenues.
The company had posted a consolidated net profit of Rs 76.91 crore for the quarter ended December 31, 2010, Torrent Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
Total income of the company stood at Rs 696.59 crore for the quarter ended December 31, 2011, as against Rs 577.53 crore for the quarter ended December 31, 2010, it added.
Torrent Pharma also said its board has declared an interim dividend of Rs 6 per equity share of Rs 5 face value.
"International revenues grew by 33% to Rs 394 crore. Operations in Brazil registered revenue growth of 27%, while Germany-based Heumann registered a revenue growth of 14%," Torrent Pharma said.
Revenues from Torrent Pharma's US operations grew by 67%, while business from Europe (other then Heumann), Russia and CIS countries and the rest of the world recorded a growth of 37%, it added.
The company is present in the cardiovascular (CV), central nervous system (CNS), gastro-intestinal, diabetology, anti-infective and pain management areas.
Shares of Torrent Pharmaceuticals closed at Rs 548.15 apiece on the BSE today, down 1.06% from their previous close.
